With a combined revenue of $21 trillion and $2.1 trillion in profits, the 2026 Fortune 500 is the definitive list of America's largest companies.

Fortune 500

Almost $20 trillion in revenue—and a record-breaking $1.87 trillion in profits. Introducing the 2025 Fortune 500, the definitive list of the biggest companies in America.

Industries included in the sector are electrical equipment and industrial machinery.

Fortune Sector Leaders: Industrials

The Fortune 500, in its 70th year in 2024, ranks the biggest U.S. companies by revenue.

The Fortune 500, in its 69th year in 2023, ranks the biggest U.S. companies by revenue.

This year’s Fortune 500 marks the 68th running of the list.

This year’s Fortune 500 marks the 67th running of the list.

In 2020, the industrial manufacturing conglomerate took in $6.6 billion in revenue, a 6% drop from the year prior, due to pandemic-related challenges to its business. But Dover outperformed its forecast during the first quarter of 2021, after demand rebounded for products including industrial pumps and food refrigeration equipment.

This year's Fortune 500 marks the 66th running of the list.

F500-2020-433-Dover

The manufacturing conglomerate makes equipment and components that can be found in pipelines for oil, gas and chemicals; in fuel pumps; and in food-service systems, among many other places.

This year's Fortune 500 marks the 65th running of the list.

Here are the World's Most Admired Companies for 2018 as ranked in their industries. See who made the list.

World's Most Admired Companies

This year's Fortune 500 marks the 64th running of the list.

This year's Fortune 500 marks the 63rd running of the list.

Here are the World's Most Admired Companies for 2016 as ranked in their industries. See who made the list.

This year's Fortune 500 marks the 62nd running of the list.

Business insiders have spoken: Asked which companies they most admire, more than 4,100 executives, directors, and analysts chose these top 50 All-Stars.

This year's Fortune 500 marks the 61st running of the list. Wal-Mart claims the top spot again. See who made the list.

Wal-Mart stayed on top as its sales crept closer to half-a-trillion dollars. Apple moved into the top five. And UnitedHealth Group continued its steady climb. 

Company Info

Industry

Location

Industry Rank

Website

Overall Score

Key Attributes Of Reputation

Innovation

People Management

Use of Corporate Assets

Social Responsibility

Quality of Management

Financial Soundness

Long-Term Investment Value

Quality of Products/Services

Global Competitiveness

Key Financials (last Fiscal Year)

Revenues ($M)

Profits ($M)

Assets ($M)

Total Stockholder Equity ($M)

Profit Ratios

Profit as % of Revenues

Profits as % of Assets

Profits as % of Stockholder Equity

Earnings Per Share (last Fiscal Year)

Earnings Per Share ($)

EPS % Change (from prior fiscal year)

EPS % Change (5 year annual rate)

EPS % Change (10 year annual rate)

Total Return

Total Return to Investors (last year)

Total Return to Investors (5 year, annualized)

Total Return to Investors (10 year, annualized)

Dover is a diversified global manufacturer delivering innovative equipment, components, consumables, software, and support services across a wide range of industries. Its segments serve critical markets including vehicle aftermarket, aerospace and defense, clean energy, retail fueling, and industrial processing. Dover’s offerings span everything from precision pumps and fluid-handling solutions to refrigeration systems, digital printing, and product-traceability technologies. With a strong focus on engineering excellence and digital innovation, Dover helps customers operate more efficiently and sustainably.

Q2 2026

Q1 2026

Q4 2025

Q2 2025

Q1 2025

Q4 2024

Dover (DOV): Company Profile, Stock Price, News, Rankings

legacy

Dover

dover

Good morning, and welcome to Dover's 4th Quarter and Full Year 2024 Earnings Conference Call. Speaking today are Richard Tobin, President and Chief Executive Officer Brad Serapak, Senior Vice President and Chief Financial Officer and Jack Dickens, Vice President, Investor Relations. Also present today is Chris Winker, Dover's segment Chief Financial Officer, who will succeed Mr. Cera Pack upon his retirement at the end of the month. After the speakers' remarks, there will be a question and answer period.

As a reminder, ladies and gentlemen, this conference call is being recorded Thank you. I'd now like to turn the call over to Mr. Jack Dickens. Please go ahead, sir.

Thank you, Margo. Good morning, everyone, and thank you for joining our call. An audio version of this call will be available on our website through February 20, and a replay link of the webcast will be archived for 90 days. Our comments today will include forward looking statements based on current expectations. Actual results and events could differ from those statements due to a number of risks and uncertainties, which are discussed in our SEC filings.

We assume no obligation to update our forward looking statements. With that, I will turn the call over to Rich.

Thanks, Jack. Good morning, everyone. Let's start on page 3. Overall, we are encouraged by the 4th quarter. Top line performance was broad based with 4 out of 5 segments posting positive organic growth and solid underlying demand across the portfolio.

Bookings were up 7% organically in the quarter, driven by robust order rates in our secular growth exposed markets as well as positive inflection and several end markets that had tough comps during the year. Our booking strength validates our previous demand outlook for 2025. Segment margin performance for the quarter was solid at 22.2%, up 60 basis points over the prior year. We are quite encouraged by the product mix impact and prior period fixed cost restructuring on segment margins during the quarter. We expect this to be a precursor of the strong incremental margin performance that we expect in 2025.

Excluding the $0.25 of tax reorganization benefit to our effective tax rate in the Q4 of the prior year, Q4 adjusted EPS grew 14% in the quarter and was up 8% for the full year. Our operational results were complemented by our ongoing portfolio actions. We recently closed 2 bolt on acquisitions within our high priority pumps and process solutions segment and our acquisition pipeline remains robust. We ended the year with a significant gas position that provides us flexibility as we pursue value creating capital deployment to further expand our businesses in high growth, high margin priority platforms through organic investment and acquisitions. We are optimistic about 2025.

Underlying demand strength has continued across the portfolio into January. We have significant runway for margin improvement through organic growth, positive mix benefits and numerous cost and performance levers. We have high confidence in Dover's attractive end market exposures, flexible business model and proven execution playbook. With this backdrop, we are poised to deliver double digit EPS growth in 2025 through a combination of accretive top line growth, margin improvement and value creating capital allocation. Let's hit to Slide 5.

Engineered products was up 2% organically in the quarter on volume growth in vehicle service and fluid dispensing. Aerospace and Defense was lower in the period due to shipment timing, but still posted a record year on growing global demand for signal intelligence and electronic warfare solutions. Clean energy and fueling was up 8% organically in the quarter, led by robust order rates and shipments within cryogenic and clean energy components as well as solid volume growth in retail fueling equipment. Our North American above ground fueling business is methodically building back to volumes from peak EMV cycle from several years ago. Importantly, there was notable growth inflection in mix accretive vehicle wash and below ground retail fueling in the quarter, which had faced tough market conditions over the last 2 years.

Margin was up 200 basis points in the quarter on positive volume leverage, attractive mix and operational execution. We expect these trends to continue to drive margins higher in 2025. Imaging and identification post another solid quarter with growth in core market in coating printers, consumable services and aftermarket parts. Margin performance was robust as management actions on cost to serve and structural cost controls continued to drive incremental margins higher. Pumps and Process Solutions is up 3% organically on robust shipments in single use biopharma components and thermal connectors, both of which posted year over year bookings growth in excess of 100% in the quarter.

Precision Components and Industrial Pumps had solid results as well as forecasted the long cycle polymer processing equipment was down year over year in the period, but was flat sequentially. Segment revenue mix drove 230 basis points of margin improvement on excellent production performance on volume growth in biopharma and thermal and margin mix benefits from the F. W. Murphy acquisition. Revenue was down in the quarter in climate sustainability technologies and expected declines in European heat exchanges and beverage making can making equipment, which more than offset the record quarterly volume in U.

S. CO2 refrigeration systems and growth in heat exchangers in the U. S. And Asia. Our shipments of heat exchangers for heat pumps in Europe did improve sequentially in the quarter, a trend we expect to accelerate in the back half of twenty twenty five as the end market recovers.

Organic bookings were up 16% in the quarter with positive booking momentum across each operating business with particular strength in CO2 systems. I'll pass it to Brad here.

Thanks, Rich. Good morning, everyone. Let's go to our cash flow statement on Slide 6. Adjusting for taxes paid on the gains on dispositions, which are non operational in nature, our free cash flow was $429,000,000 in the quarter or 22 percent of revenue. Our Q4 was our highest cash flow quarter of the year in line with historical trends.

We are pleased with our full year adjusted free cash flow generation, which came in at 13.5 percent of revenue, within our guidance range despite carrying large accounts receivable balances at the year end. That will be a credit to early 2025 cash generation. Our guidance for 2025 free cash flow is 14% to 16% of revenue on strong conversion of operating cash flow. We are forecasting slightly higher CapEx in 2025 on several growth investments. With that, I'll turn it back to Rich.

Thanks. I'm on slide 7. Here we provide a little more detail on the bookings momentum in the Q4. Q4 marked our 5th consecutive quarter of positive year over year bookings growth, posting a book to bill above 1. As shown in the segment detail on the right, the bookings rates were broad based with particular strength in our secular growth exposed markets providing a strong foundation as we move into 2025.

Slide 8 highlights several end markets that were driving our consolidated organic growth forecast. Between end market data, our customer forecasts and our own booking rates, we are encouraged with the outlook in the broader industrial gas complex within clean energy and precision components, single use biopharma components, CO2 refrigeration systems and inputs into liquid cooling applications of data centers, which include our connectors as well as heat exchangers. We have made significant organic and inorganic investment behind these end markets, which we'll continue to prioritize into 2025. In aggregate, these markets now account for 20% of our portfolio and drive attractive margin accretion on expected double digit growth rates. Moving to slide 9.

We expect Engineered Products to grow low single digits organically on sustained strong orders and shipments within Aerospace and Defense, which should be levered to the second half of the year due to the timing of government programs. With the divestitures of Distaco and Environmental Services Solutions Group in 2024, our Engineered Products segment now accounts for roughly 15% of our total portfolio, down from 25% in the prior year. We are optimistic about the growth outlook in clean energy and fueling, which should return to positive volume growth due to strength in clean energy components, fluid transport and above ground fueling. We expect this segment to be among the leaders in margin accretion in 2025 on volume leverage, positive mix from below ground fueling. Additionally, we can expect additional carryover of multiyear restructuring actions and acquisition integration benefits, which will primarily accrue in the second half of the year.

We expect Imaging ID to continue its long term steady growth trajectory given its significant reoccurring revenue base and solid demand profile across all geographies. Management has done yeoman's work to improve the margin here through productivity and structural cost controls and we believe there are multiple years ahead of continued margin accretion. Underlying demand trends across pumps and process solutions remain solid. Shipments of single use biopharma components should continue their double digit growth rate driven by production growth in blockbuster drugs and the emergence of novel technologies such as cell and gene therapies and the continued secular shift towards stage and use manufacturing. The outlook for thermal connectors for liquid cooling data centers is robust.

Our preemptive capacity expansion has allowed us to maintain industry best lead times in what has turned out to be a short cycle business. Our precision components business is directly levered to energy complex investments, so we are quite interested to see how that plays out in 2025. Finally, climate and sustainability technology should recover well as difficult comps roll off and heat exchangers and beverage can making with the recent launch of our high capacity platform and CO2 refrigeration systems, we have the broadest product offering in the industry. We are currently taking orders well into the second half of twenty twenty five and should continue to grow at double digit rate due to the broad based adoption among national retailers. Heat exchanger expected to grow as European heat pump channel inventories have been largely depleted.

We are forecasting sustained growth in North American heat exchangers. We have completed a capacity expansion for large format production driven in part by liquid cooling applications in data centers. Our guide let me finish up on Slide 10. Our guidance this year is a bit unique since we provided preliminary outlook for 2025 during last quarter's earnings release, which we felt was necessary given the significant portfolio moves completed in Q4. Our 2025 guidance is in line.

That preliminary outlook from a quarter ago in terms of organic revenue and EPS growth with the underlying building blocks intact. There has only been one noteworthy change from last quarter, which is heightened foreign exchange translation headwind from the strengthening U. S. Dollar. While this incremental headwind, which is by no means unique to Dover, we are confident in holding our full year guide due to the positive and broad based bookings momentum we had during the year.

So pretty much we're going to eat everything that we saw when we ran from October to January in terms of FX, which is not a little bit. We enter 2025 in advantaged cash position. Our preference is to deploy capital towards organic growth investments and our inorganic growth pipeline, which has improved in both quantity and quality of opportunities over the last several months. Rest assured, we will proceed with the capital discipline that we have demonstrated in the past. Finally, before we move to Q and A, I'd like to take a moment to recognize and congratulate Brad on his retirement.

Since joining Dover over 15 years ago, he has been instrumental, strategic and financial leader who has helped transform Dover to our current operating structure today. I'm sure Brad couldn't think of a better send off than spend his last days preparing for this earnings call. On behalf of all of us, thank you and we wish you all the best.

Thank you for that, Rich. Much appreciated. It's been absolutely a pleasure to work with you, the entire Dover team, our Board and of course the finance organization for so many years. Chris Winker will take it from here and I wish him the very best. Okay.

Thank you. And we'll now take our first question from Steve Tusa with JPMorgan. Please go ahead.

Brad, congrats and thanks for all the help over the years. You've definitely seen a lot there, a lot of change. So congrats on the run. The slide last quarter talked about 40% conversion and $25,000,000 of restructuring benefits. This slide says 40% plus.

Are you still assuming the $25,000,000 of restructuring benefits? And I don't know, there's a lot of like up arrows on that margin slide. So just maybe help calibrate us a bit on the margin drivers and price costs?

Sure. Like the restructuring benefit hasn't changed. As I mentioned last quarter, we'll we've got some more in the pipe and when we do it, we'll give you the roll forward benefit of it, which is not embedded into our forecast presently. The balance of it is mix. So if you look at the margin accretion that we saw in Q4, I think it's a pretty good precursor of what we can expect.

And then we'll see from there. Then it's just a question of kind of the volume that we see. So right now, we're going to stick to the 40%. I think I don't see that going up in a percentage basis. It will be more tied to are we underestimating the revenue growth potential into 2025.

Bookings look great, but let's see. Let's get through a quarter or 2.

Got it. And price cost, what do you guys assume for price on the year and will that spread be positive?

It will be positive, not a lot either way in terms of benefit, maybe a point, point and a half. We'll see. It depends on the mix that we get, but it will be positive.

Okay, great. Thanks a lot. Thanks again, Brad. Congrats.

Thank you. And next we'll take a question from Nigel Coe with Wolfe Research. Please go ahead.

Thanks. Good morning. Brad, I'm sure you're going to get a lot of congratulations and all that. But you've been at Dover for a long time. You've been the one sort of constant for the last like 15 years.

So it's quite a moment here. So congratulations.

No, no. So Rich, you mentioned January and whenever you mentioned sort of within the current period, it always sparks a bit of potential. I'm just curious if you think that tariffs or the potential tariffs is causing any sort of unusual behavior around the supply chain that you touch?

No, we don't see it. I mean, we're generally speaking a proximity manufacturer. So our backlogs are more influenced on the lead times of the individual products, which are kind of all over the place between the short cycle and the long cycle. But yes, I don't we don't see any let's get in front of this because we think that there's going to be tariffs. We have a few businesses that are global in nature, but the vast majority of it is proximity.

Okay. Okay. And then just a quick question on the margin outlook. You mentioned CEF is going to be the margin leader. I'm just curious if we could just maybe just if I could just ask if the 20% plus handle would be reasonable there just based on what we saw this quarter?

And then similar vein with DPPS just given the exit rate, would a 30 handle be reasonable for this year?

Look, I think that the absolute change in margin we would expect in DCEF, okay? We are driving at the segment level in excess of 20, all right? You may not get it every quarter depending on the cyclicality of it, but clearly at an exit rate in excess of 2020. On DPPS, it's all about the mix. So if we're under calling biopharma and we get better results there, then clearly they will mix up.

But if Precision Components does better, it's a little bit dilutive, but it's still at 25% margin, so we'll take it all day long. So it's more a question of what we get in terms of mix going from here.

Thank you. We'll next go to Andy Kaplowitz with Citigroup. Please go ahead.

Good morning, everyone. Hi, Andy. Brad, thanks for all your help. Congrats.

Rich, book to bill over 1 again in Q4, are you thinking 'twenty five is another year where all or most of your quarters could achieve book to bill out or over 1? And I know you're expecting an inflection in CO2 orders. It looks like you've got that and you mentioned the double digit expected growth in that business is expected to continue. But given recovery in other DCST businesses, at least in terms of orders, it seems like you expect DCST bookings momentum to continue. Maybe you can comment on that specifically?

I mean, I would expect based on our growth rate we'll hover around 1. I mean I don't think we get all excited if it's 0.98 1 quarter. But we should hover around 1 for the year and then we'll make a call on Q4 as we exit. Yes, I mean we did get some bookings in Q4 in CO2 systems. We've got a lot coming our way.

So I would expect bookings to look good there coupled with the fact maybe not in Q1, but as we go into Q2, we'll inflect positive bookings in heat exchangers. So that will help in terms of the

can you give us a little more color into how you think about earnings cadence through the year? It seems like we start out pretty slowly in terms of organic growth in Q1, given DCST and DP could start slowly in terms of growth, but more color on Q1 and the trajectory for the rest of

Yes. I mean, I'll go back to now that we're beyond kind of all the COVID stuff, we'll go back to we'll start off a little slowly. We'll probably build a bunch of inventory in Q1 that will recognize those revenues in Q2 and Q3. And then Q4, like every other year, we'll decide on the outlook of 2025 how we run production, but we'll make those decisions in the August, September timeframe.

So yes, I mean, I think that quarter to quarter will look okay, but I mean, it will be a ramp into Q2 and Q3.

You. And we're next going to take our next question from Joe Ritchie with Goldman Sachs. Please go ahead.

Hey, guys. Good morning. And Brad, thanks so much. Wish you nothing but the best.

Maybe let's just I'll just hone my questions in on DCST. Rich, maybe talk a little bit about like what you're seeing in that European heat pump market now expecting growth in 2025. I think you may be mentioned inventories have also stabilized there. Just give us some color on what you're seeing there.

Well, I mean the margin performance that you see for us in Q4 is us basically under producing severely. So it was a willful attempt to force inventory clearing out of the channel. But having said that, orders inflected positively, let's not get excited off of some pretty low levels. So I would say that we did our part to allow inventory to clear and just sequentially orders are coming up. It's probably still got a bad comp in Q1.

But then from there, we would expect to ramp over the balance of the year. What that ramp looks like, we're taking our best estimates right now. As you know, getting good data out of our own customers has been quite difficult, but we would expect I think that we've got a prudent outlook for it. And hopefully, it gets sequentially better over the year. But what we're confident about is, we took some direct action to allow inventory to clear in the back half of the year.

Got it. That makes a lot of sense. So as you think about then kind of like the right starting point for margins for that segment, given that you put that big hit in the Q4, like how do you think about then the margin trajectory in 2025? It would seem like you should get some pretty good margin expansion in that business.

Yes. I mean once we lap Q1, Q1 is always a little bit messy because in traditional refrigeration equipment, it's not a heavy shipment month. We tend to build inventory there as opposed to shipping it. And as I said, SWEP on heat exchangers has probably got a tough comp there. Having said all that, that we were very pleased with the margin that we got, the exit margin that we got at refrigeration.

So that's what we're booking in for the balance of the year. And to the extent we under produce so severely in heat exchangers, we have like negative fixed cost absorption there. In Q4, we'd expect that to get better over time. So net net, if you just look through the downturn in heat exchangers, with all the progress that we made on refrigeration, we would expect that we would be maybe not at record margins because I'd have to kind of triangulate for Belvac a little bit, but some very good margins in that segment if we were to benchmark it historically.

Thank you. Our next question will come from Brett Linzey with Mizuho. Please go ahead.

Thanks. Good morning and best of luck to Brad.

Hey, wanted to come back to the bio orders really strong. I guess any detail in the nature of the applications you're winning? And any concentration, is there 1 to 2 customers? Is it fairly broad based? And then how should we think about that delivery schedule?

It is broad based. I mean, we cleared inventory in the back half or the front half of this year. And then we started orders inflected, I think, more or less at the end of Q2. We don't know a lot in terms of where it ends up because there's a big portion that sell through from our clients at the end of the day. But I think I would categorize it as we are a supplier to in use production and that the inventory is cleared out of the system and that those units are operating now and it's just pull through.

a follow-up on the liquid cooling, very strong demand again, obviously with everything that's going on. But maybe talk about that specification process with those partners. And how large has the total addressable market for Dover grown over the last couple of years? And where do you think your share of that can run?

Well, it's grown significantly because it was a traditional product of ours that have been supplied into supercomputing applications. What the TAM is, is anybody's guess right now. If you go back and look at the transcript, I think that we made the right decision in terms of having the product available and we made the right decision to build out the capacity in advance of the demand because it has turned out what I would have thought to be a business that would have because of the build out time for these data centers that we you would know when the orders are coming. It's turned out to be a very short cycle business for us. So the data that we get of where the product is going is almost at the last minute.

Now we've been a market share winner here because we've got the capacity installed, to the detriment of some of the working capital, I would say, in the Q4 of this year. But I can't even give you TAM numbers, quite frankly. I don't think anybody knows. We'll see how it plays out. But right now, super proud of the management team in terms of how they've managed a credibly complex situation.

Thank you. Our next question comes from Michael Halloran with Baird. Please go ahead.

Hey, good morning everyone and congrats Brad.

So just another high level question here, just make sure I understand the cadencing through the year. In an answer to the earlier questions, the thought process then, if I think about typical earnings by quarter, relatively normal or a little subdued in the first and then build it up in the back. But then related, are you basically assuming the underlying demand dynamics are relatively stable with current levels, not improving, not getting worse, but relatively stable in normal sequentials? Is that the thought process?

Yes. I think the sequential should be relatively stable and typically from a calendarization point of view. So there's nothing and the mix benefit should be relatively stable. But when we're talking about the incremental growth on the roll forward, then you're going to get the growth most of the growth in Q2 and Q3. So it doesn't leg down and then leg up.

It kind of just sequentially rolls forward. The mix impact on the business should be relatively stable, right, because that's if you look at the order rates, that's where we're going to be shipping out of. And then the growth that we're getting, which will be producing in Q1 will be shipped out in Q2 and Q3. That's our estimates right now.

Yes. That makes sense. And then just an update on the M and A side. Any change to what you're seeing from a backdrop, actionability and the amount of content that might be in the market at some point?

Yes, lots of stuff coming. We're really interested to see what the spirits are out there and what we'd like to see a couple of transactions to get done. There's quite a few in the pipe to see at what how aggressive everybody is going to be at valuation. But those are the ones everybody knows about. We've also got a handful of very interesting proprietary deals that we're working on.

So we'll see. I mean, we're very popular in multi industrial world because of all the cash flow we're sitting on. So we're seeing a lot. Time will tell about what multiples look like when we see a couple of transactions.

Yes. And keep in mind that that cash on the balance sheet right now is not deployed in our forecast. It's generating nice interest income. So it doesn't burn a hole in our pocket, so to speak. And when you think about your models, just keep in mind that we're sticking to our $0.50 year over year concept around interest income until we deploy that capital.

And then you'll see a shift between the interest line and the segment performance line as

We'll take our next question from Julian Mitchell with Barclays. Please go ahead.

Hi, thanks. Good morning and Brad, thanks for all the help. If we think about just the segment level, I wanted to start with clean energy and fueling. It seemed like you did see some very encouraging signs exiting the year in below ground and vehicle wash. And as we're thinking about the 2025 guidance, maybe help us understand kind of how much of the business now is that clean energy components piece, which is sort of come together fairly recently?

Dover (DOV) Q4 2024 Earnings Call Transcript

Company Participants